Therapy of Primary Liver Cancer
Primary liver cancer (PLC) is a fatal disease that affects millions of lives worldwide. PLC is the leading cause of cancer-related deaths and the incidence rate is predicted to rise in the coming decades. PLC can be categorized into three major histological subtypes: hepatocellular carcinoma (HCC),...
Main Authors: | Mei Feng, Yisheng Pan, Ruirui Kong, Shaokun Shu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-08-01
|
Series: | The Innovation |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666675820300321 |
Similar Items
-
Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection
by: Shuo Shao, et al.
Published: (2020-01-01) -
Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma
by: Alexander A. Azizi, et al.
Published: (2020-09-01) -
Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma
by: Lang Chen, et al.
Published: (2020-02-01) -
Primary liver cancer in the UK: Incidence, incidence-based mortality, and survival by subtype, sex, and nation
by: Anya Burton, et al.
Published: (2021-04-01) -
MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma
by: Jennifer Sammon, et al.
Published: (2018-02-01)